Medicare Enrolled

Dr. Aaron Pumerantz, D.O.

Rheumatology · Toledo, OH
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
4235 SECOR RD, Toledo, OH 43623
4194795860
Registered in NPPES since 2009
NPI: 1407088438 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Pumerantz from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Pumerantz? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Pumerantz

Dr. Aaron Pumerantz is a rheumatology specialist in Toledo, OH, with 17 years of NPI registration. Based on federal Medicare data, Dr. Pumerantz performed 80,863 Medicare services in 2023. These records do not provide a deduplicated patient total.

Between the years covered by Open Payments, Dr. Pumerantz received a total of $10,148 from 28 pharmaceutical and/or device companies across 499 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Pumerantz is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 17 years of NPI registration ▲ Top 5% volume in OH $10,148 industry payments

Medicare Practice Summary — 2023

Medicare Utilization ↗
80,863
Medicare services
Top 5% in OH for rheumatology
Not available
Unique patients (not deduplicated)
$12
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Tocilizumab injection (Actemra) 44,720 $5 $8
Golimumab infusion (Simponi Aria)
Administration of golimumab medication directly into a vein. This code specifies the dosage amount of 1 milligram for intravenous delivery.
15,950 $11 $49
Abatacept infusion (Orencia)
An injection of abatacept administered under the direct supervision of a physician. This code is used for Medicare when the drug is not self-administered.
9,975 $34 $84
Denosumab injection (Prolia/Xgeva) 3,540 $18 $33
Infliximab infusion (Remicade)
An injection of infliximab, excluding biosimilar versions, administered in a 10 mg dose.
3,530 $26 $165
Steroid injection (triamcinolone)
A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered.
1,296 $1 $4
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
685 $86 $208
Intravenous infusion, 1 hour or less
Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less.
325 $47 $130
Additional hour of intravenous chemotherapy
This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period.
162 $20 $54
Normal saline infusion, 250 cc
Administration of 250 cubic centimeters of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater fluid.
137 $0 $9
Joint injection, major joint
Removal of fluid from a large joint and/or injection of medication into the joint space.
115 $54 $158
Intravenous chemotherapy infusion, 1 hour or less
Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete.
113 $94 $253
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
55 $11 $48
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
55 $122 $281
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
52 $92 $320
Joint fluid aspiration or injection, small joint
Removal of fluid from a small joint or injection of medication into a small joint.
46 $35 $108
New patient office visit, complex (60-74 min) 34 $157 $403
Intravenous injection of additional new drug or substance
Administration of an additional new medication or substance directly into a vein.
31 $11 $42
Injection, methylprednisolone acetate, 40 mg 28 $6 $16
Trigger point injection, 1-2 muscles
A procedure involving the injection of medication into one or two specific muscles to treat trigger points.
14 $34 $107
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
37.1% high complexity
61.8% medium
1.0% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$10,148
Total received (2018-2024)
Avg $1,450/year across 7 years
Top 24% in OH for rheumatology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
28
Companies
499
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,557
2023
$1,690
2022
$1,100
2021
$842
2020
$744
2019
$2,081
2018
$1,134

Payments by company (2024)

ABBVIE INC.
$982
Janssen Biotech, Inc.
$437
Amgen Inc.
$256
AstraZeneca Pharmaceuticals LP
$214
Novartis Pharmaceuticals Corporation
$157
Kiniksa Pharmaceuticals International, plc
$125
HydroCision, Inc.
$84
GlaxoSmithKline, LLC.
$82
E.R. Squibb & Sons, L.L.C.
$76
PFIZER INC.
$25
Alvogen Inc
$23
Lilly USA, LLC
$22
Boehringer Ingelheim Pharmaceuticals, Inc.
$21
Organon Llc
$20
Genentech USA, Inc.
$17
UCB, Inc.
$15
Top 3 companies account for 65.5% of 2024 payments
All-time payments by company (2018-2024) ›
ABBVIE INC.
$1,893
Amgen Inc.
$1,517
Janssen Biotech, Inc.
$1,430
UCB, Inc.
$850
Novartis Pharmaceuticals Corporation
$503
AbbVie Inc.
$503
PFIZER INC.
$489
Lilly USA, LLC
$421
Genentech USA, Inc.
$420
E.R. Squibb & Sons, L.L.C.
$330
GlaxoSmithKline, LLC.
$307
AstraZeneca Pharmaceuticals LP
$265
Regeneron Healthcare Solutions, Inc.
$205
AbbVie, Inc.
$162
Celgene Corporation
$160
Kiniksa Pharmaceuticals International, plc
$125
NOVARTIS PHARMACEUTICALS CORPORATION
$97
Biocompatibles, Inc.
$92
Boehringer Ingelheim Pharmaceuticals, Inc.
$88
HydroCision, Inc.
$84
Mallinckrodt Hospital Products Inc.
$44
Fresenius Kabi USA, LLC
$34
Horizon Therapeutics plc
$28
Daiichi Sankyo Inc.
$27
Alvogen Inc
$23
Organon Llc
$20
Merck Sharp & Dohme Corporation
$17
Actelion Pharmaceuticals US, Inc.
$15
Top 3 companies account for 47.7% of all-time payments
Associated products mentioned in payments ›
ACTHAR · AVSOLA · Actemra · Arcalyst · BENLYSTA · COSENTYX · CYLTEZO · Cimzia · EVENITY · Enbrel · FORTEO · HUMIRA · Humira · IDACIO · INFLECTRA · INJECTAFER · KEVZARA · KEVZARA SARILUMAB INJECTION · KRYSTEXXA · LYRICA · OLUMIANT · OPSUMIT · ORENCIA · Otezla · Prolia · RAYOS · REMICADE · RENFLEXIS · RINVOQ · Rinvoq · Rituxan · SAPHNELO · SIMPONI ARIA · SKYRIZI · TALTZ · TAVNEOS · TENJET · TERIPARATIDE · TREMFYA · VARITHENA · XELJANZ
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for a rheumatology specialist in Toledo?
Compare rheumatologists in the Toledo area by procedure volume, costs, and industry payment transparency.
Browse rheumatologists nearby

Geographic Context

Rheumatologists in nearby ZIP areas
14
County median income
$60,095
Nearest hospital to ZIP centroid (approximate)
PROMEDICA TOLEDO HOSPITAL
2.9 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment PECOS PECOS snapshot
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Pumerantz is a mixed practice specialist, with above-average Medicare volume (top 5% in OH), with 17 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Pumerantz experienced with tocilizumab injection (actemra)?
Based on Medicare claims data, Dr. Pumerantz performed 44,720 tocilizumab injection (actemra) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Pumerantz receive payments from pharmaceutical companies?
Yes. Dr. Pumerantz received a total of $10,148 from 28 companies across 499 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Pumerantz's costs compare to other rheumatologists in Toledo?
Dr. Pumerantz's average Medicare payment per service is $12. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Pumerantz) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →